Review of ultrasound mediated drug delivery for cancer treatment: Updates from pre-clinical studies

Translational Cancer Research

Volumn 3, Issue 5, 2014, Pages 494-511

  Couture, Olivier ^a   Foley, Jessica ^b   Kassell, Neal F ^b,c   Larrat, Benoit ^d   Aubry, Jean Francois ^a,e  

^a INSTITUT LANGEVIN   (France)

^b Focused Ultrasound Foundation   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d DIF   (France)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Blood brain barrier (BBB); Drug delivery; Targeted therapy; Ultrasound

Indexed keywords

EID: 84962741988     PISSN: 2218676X     EISSN: 22196803     Source Type: Journal    
DOI: 10.3978/j.issn.2218-676X.2014.10.01     Document Type: Review

References (176)

1. Mukherjee S. eds. The emperor of all maladies: a biography of cancer. New York: Simon and Schuster; 2011.
2. Herodotus. The Histories 440BC:3.133. Available online: http://classics.mit.edu/Herodotus/history.3.iii.html
3. DeVita VT Jr, Chu E. A history of cancer chemotherapy. Cancer Res 2008;68:8643-53.
4. Chabner BA, Roberts TG Jr. Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer 2005;5:65-72.
5. Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer 2006;6:583-92.
6. Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvasc Res 2007;74:72-84.
7. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev 2008;60:1193-208.
8. Goel S, Duda DG, Xu L, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 2011;91:1071-121.
9. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9.
10. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685-93.
11. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988;48:2641-58.
12. Pennacchietti S, Michieli P, Galluzzo M, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003;3:347-61.
13. Chang YS, di Tomaso E, McDonald DM, et al. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 2000;97:14608-13.
14. Morikawa S, Baluk P, Kaidoh T, et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002;160:985-1000.
15. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003;9:713-25.
16. Winkler F, Kozin SV, Tong RT, et al. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 2004;6:553-63.
17. Heldin CH, Rubin K, Pietras K, et al. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 2004;4:806-13.
18. Tacker JR, Anderson RU. Delivery of antitumor drug to bladder cancer by use of phase transition liposomes and hyperthermia. J Urol 1982;127:1211-4.
19. Lorenzato C, Cernicanu A, Meyre ME, et al. MRI contrast variation of thermosensitive magnetoliposomes triggered by focused ultrasound: a tool for image-guided local drug delivery. Contrast Media Mol Imaging 2013;8:185-92.
20. Escoffre JM, Mannaris C, Geers B, et al. Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery. IEEE Trans Ultrason Ferroelectr Freq Control 2013;60:78-87.
21. Luan Y, Faez T, Gelderblom E, et al. Acoustical properties of individual liposome-loaded microbubbles. Ultrasound Med Biol 2012;38:2174-85.
22. Mannaris C, Efthymiou E, Meyre ME, et al. In vitro localized release of thermosensitive liposomes with ultrasound-induced hyperthermia. Ultrasound Med Biol 2013;39:2011-20.
23. Grüll H, Langereis S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release 2012;161:317-27.
24. Geers B, Lentacker I, Sanders NN, et al. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery. J Control Release 2011;152:249-56.
25. Böhmer MR, Chlon CH, Raju BI, et al. Focused ultrasound and microbubbles for enhanced extravasation. J Control Release 2010;148:18-24.
26. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968;3:356-66.
27. Weinstein JN, Magin RL, Yatvin MB, et al. Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. Science 1979;204:188-91.
28. Ta T, Porter TM. Thermosensitive liposomes for localized delivery and triggered release of chemotherapy. J Control Release 2013;169:112-25.
29. Schroeder A, Kost J, Barenholz Y. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem Phys Lipids 2009;162:1-16.
30. Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 2013;65:36-48.
31. Weinstein JN, Magin RL, Yatvin MB, et al. Liposomes and local hyperthermia: selective delivery of methotrexate to heated tumors. Science 1979;204:188-91.
32. Barenholz Y. Doxil®--the first FDA-approved nano-drug: lessons learned. J Control Release 2012;160:117-34.
33. Al-Ahmady ZS, Al-Jamal WT, Bossche JV, et al. Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo. ACS Nano 2012;6:9335-46.
34. Faez T, Emmer M, Kooiman K, et al. 20 years of ultrasound contrast agent modeling. IEEE Trans Ultrason Ferroelectr Freq Control 2013;60:7-20.
35. Hernot S, Unnikrishnan S, Du Z, et al. Nanobody-coupled microbubbles as novel molecular tracer. J Control Release 2012;158:346-53.
36. Kooiman K, Vos HJ, Versluis M, et al. Acoustic behavior of microbubbles and implications for drug delivery. Adv Drug Deliv Rev 2014;72:28-48.
37. Lentacker I, Lentacker I, Smedt S, et al. Drug loaded microbubble design for ultrasound triggered delivery. Soft Matter 2009;1-10.
38. Fokong S, Theek B, Wu Z, et al. Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles. J Control Release 2012;163:75-81.
39. Lentacker I, Geers B, Demeester J, et al. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther 2010;18:101-8.
40. Geers B, Dewitte H, De Smedt SC, et al. Crucial factors and emerging concepts in ultrasound-triggered drug delivery. J Control Release 2012;164:248-55.
41. Suzuki R, Takizawa T, Negishi Y, et al. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release 2007;117:130-6.
42. Gao Z, Fain HD, Rapoport N. Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol Pharm 2004;1:317-30.
43. Somaglino L, Bouchoux G, Mestas JL, et al. Validation of an acoustic cavitation dose with hydroxyl radical production generated by inertial cavitation in pulsed mode: application to in vitro drug release from liposomes. Ultrason Sonochem 2011;18:577-88.
44. Oerlemans C, Deckers R, Storm G, et al. Evidence for a new mechanism behind HIFU-triggered release from liposomes. J Control Release 2013;168:327-33.
45. Sheeran PS, Wong VP, Luois S, et al. Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging. Ultrasound Med Biol 2011;37:1518-30.
46. Fabiilli ML, Haworth KJ, Sebastian IE, et al. Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion. Ultrasound Med Biol 2010;36:1364-75.
47. Couture O, Faivre M, Pannacci N, et al. Ultrasound internal tattooing. Med Phys 2011;38:1116-23.
48. Shpak O, Verweij M, Vos HJ, et al. Acoustic droplet vaporization is initiated by superharmonic focusing. Proc Natl Acad Sci U S A 2014;111:1697-702.
49. McDannold N, Vykhodtseva N, Raymond S, et al. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 2005;31:1527-37.
50. Couture O, Urban A, Bretagne A, et al. In vivo targeted delivery of large payloads with an ultrasound clinical scanner. Med Phys 2012;39:5229-37.
51. Kawabata K, Sugita N, Yoshikawa H, et al. Nanoparticles with Multiple Perfluorocarbons for Controllable Ultrasonically Induced Phase Shifting. Jpn J Appl Phys 2005;44:4548-52.
52. Javadi M, Pitt WG, Belnap DM, et al. Encapsulating nanoemulsions inside eLiposomes for ultrasonic drug delivery. Langmuir 2012;28:14720-9.
53. Couture O, Pannacci N, Babataheri A, et al. Ultrasound-inducible fluorescent particles for internal tattooing. Ultrasonics Symposium (IUS), IEEE International 2009;85-8.
54. Fabiilli ML, Lee JA, Kripfgans OD, et al. Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions. Pharm Res 2010;27:2753-65.
55. Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008;60:1153-66.
56. Owen J, Pankhurst Q, Stride E. Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination. Int J Hyperthermia 2012;28:362-73.
57. Zhao S, Borden M, Bloch SH, et al. Radiation-force assisted targeting facilitates ultrasonic molecular imaging. Mol Imaging 2004;3:135-48.
58. Fabiilli ML, Piert MR, Koeppe RA, et al. Assessment of the biodistribution of an [(18) F]FDG-loaded perfluorocarbon double emulsion using dynamic micro-PET in rats. Contrast Media Mol Imaging 2013;8:366-74.
59. Maeda H. Macromolecular therapeutics in cancer treatment: the EPR effect and beyond. J Control Release 2012;164:138-44.
60. Rapoport N. Ultrasound-mediated micellar drug delivery. Int J Hyperthermia 2012;28:374-85.
61. Bassett JB, Anderson RU, Tacker JR. Use of temperature-sensitive liposomes in the selective delivery of methotrexate and cis-platinum analogues to murine bladder tumor. J Urol 1986;135:612-5.
62. Koning GA, Eggermont AM, Lindner LH, et al. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors. Pharm Res 2010;27:1750-4.
63. Rapoport NY, Kennedy AM, Shea JE, et al. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release 2009;138:268-76.
64. Mo S, Coussios CC, Seymour L, et al. Ultrasound-enhanced drug delivery for cancer. Expert Opin Drug Deliv 2012;9:1525-38.
65. Dromi S, Frenkel V, Luk A, et al. Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res 2007;13:2722-7.
66. Frenkel V, Etherington A, Greene M, et al. Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. Acad Radiol 2006;13:469-79.
67. Ning S, Macleod K, Abra RM, et al. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int J Radiat Oncol Biol Phys 1994;29:827-34.
68. Ranjan A, Jacobs GC, Woods DL, et al. Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release 2012;158:487-94.
69. Kheirolomoom A, Lai CY, Tam SM, et al. Complete regression of local cancer using temperature-sensitive liposomes combined with ultrasound-mediated hyperthermia. J Control Release 2013;172:266-73.
70. Lentacker I, Geers B, Demeester J, et al. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther 2010;18:101-8.
71. Tinkov S, Coester C, Serba S, et al. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization. J Control Release 2010;148:368-72.
72. Staples BJ, Pitt WG, Roeder BL, et al. Distribution of doxorubicin in rats undergoing ultrasonic drug delivery. J Pharm Sci 2010;99:3122-31.
73. Cochran MC, Eisenbrey J, Ouma RO, et al. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm 2011;414:161-70.
74. Targeted Chemotherapy Using Focused Ultrasound for Liver Metastases (TARDOX). Available online: http://clinicaltrials.gov/show/NCT02181075
75. Rychak JJ, Klibanov AL. Nucleic acid delivery with microbubbles and ultrasound Adv Drug Deliv Rev 2014;72:82-93.
76. Unger E, Porter T, Lindner J, et al. Cardiovascular drug delivery with ultrasound and microbubbles. Adv Drug Deliv Rev 2014;72:110-26.
77. Greenleaf WJ, Bolander ME, Sarkar G, et al. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998;24:587-95.
78. Unger EC, McCreery TP, Sweitzer RH. Ultrasound enhances gene expression of liposomal transfection. Invest Radiol 1997;32:723-7.
79. Anwer K, Kao G, Proctor B, et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther 2000;7:1833-9.
80. Negishi Y, Endo Y, Fukuyama T, et al. Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound. J Control Release 2008;132:124-30.
81. Carson AR, McTiernan CF, Lavery L, et al. Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res 2012;72:6191-9.
82. Carson AR, McTiernan CF, Lavery L, et al. Gene therapy of carcinoma using ultrasound-targeted microbubble destruction. Ultrasound Med Biol 2011;37:393-402.
83. Wang DS, Panje C, Pysz MA, et al. Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology 2012;264:721-32.
84. Bazan-Peregrino M, Rifai B, Carlisle RC, et al. Cavitation-enhanced delivery of a replicating oncolytic adenovirus to tumors using focused ultrasound. J Control Release 2013;169:40-7.
85. Unga J, Hashida M. Ultrasound induced cancer immunotherapy. Adv Drug Deliv Rev 2014;72:144-53.
86. Xing Y, Lu X, Pua EC, et al. The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model. Biochem Biophys Res Commun 2008;375:645-50.
87. Zhang Y, Deng J, Feng J, et al. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound. World J Gastroenterol 2010;16:3584-91.
88. De Temmerman ML, Dewitte H, Vandenbroucke RE, et al. mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells. Biomaterials 2011;32:9128-35.
89. Un K, Kawakami S, Suzuki R, et al. Development of an ultrasound-responsive and mannose-modified gene carrier for DNA vaccine therapy. Biomaterials 2010;31:7813-26.
90. Bezagu M, Errico C, Chaulot-Talmon V, et al. High spatiotemporal control of spontaneous reactions using ultrasound-triggered composite droplets. J Am Chem Soc 2014;136:7205-8.
91. Pardridge WM. Drug transport across the blood-brain barrier. Journal of Cerebral Blood Flow & Metabolism 2012;32:1959-72.
92. Gaillard PJ, Visser CC, de Boer M, et al. Blood-to-brain drug delivery using nanocarriers. In: Hammarlund-Udenaes M, de Lange E, Thorne RG, et al. eds. Drug Delivery to the Brain. Berlin: Springer, 2014;433-54.
93. Hammarlund-Udenaes M, de Lange E, Thorne RG, et al. eds. Drug Delivery to the Brain. Berlin: Springer, 2014.
94. Hynynen K, McDannold N, Vykhodtseva N, et al. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001;220:640-6.
95. Aryal M, Arvanitis CD, Alexander PM, et al. Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. Adv Drug Deliv Rev 2014;72:94-109.
96. Tachibana K, Feril LB Jr, Ikeda-Dantsuji Y. Sonodynamic therapy. Ultrasonics 2008;48:253-9.
97. Marty B, Larrat B, Van Landeghem M, et al. Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis. J Cereb Blood Flow Metab 2012;32:1948-58.
98. Kinoshita M, McDannold N, Jolesz FA, et al. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci U S A 2006;103:11719-23.
99. Treat LH, McDannold N, Vykhodtseva N, et al. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007;121:901-7.
100. Mei J, Cheng Y, Song Y, et al. Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound. J Ultrasound Med 2009;28:871-80.
101. Zeng HQ, Lü L, Wang F, et al. Focused ultrasound-induced blood-brain barrier disruption enhances the delivery of cytarabine to the rat brain. J Chemother 2012;24:358-63.
102. Park J, Zhang Y, Vykhodtseva N, et al. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. J Control Release 2012;162:134-42.
103. Huang Q, Deng J, Wang F, et al. Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Exp Neurol 2012;233:350-6.
104. Thévenot E, Jordão JF, O'Reilly MA, et al. Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound. Hum Gene Ther 2012;23:1144-55.
105. Alonso A, Reinz E, Leuchs B, et al. Focal Delivery of AAV2/1-transgenes Into the Rat Brain by Localized Ultrasound-induced BBB Opening. Mol Ther Nucleic Acids 2013;2:e73.
106. Hsu PH, Wei KC, Huang CY, et al. Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound. PLoS One 2013;8:e57682.
107. Liu HL, Fan CH, Ting CY, et al. Combining microbubbles and ultrasound for drug delivery to brain tumors: current progress and overview. Theranostics 2014;4:432-44.
108. Kovacs Z, Werner B, Rassi A, et al. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J Control Release 2014;187:74-82.
109. Burke CW, Alexander E 4th, Timbie K, et al. Ultrasound-activated agents comprised of 5FU-bearing nanoparticles bonded to microbubbles inhibit solid tumor growth and improve survival. Mol Ther 2014;22:321-8.
110. Aryal M, Vykhodtseva N, Zhang YZ, et al. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release 2013;169:103-11.
111. Wei KC, Chu PC, Wang HY, et al. Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study. PloS one 2013;8:e58995.
112. Fan CH, Ting CY, Liu HL, et al. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials 2013;34:2142-55.
113. Fan CH, Ting CY, Lin HJ, et al. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery. Biomaterials 2013;34:3706-15.
114. Alkins R, Burgess A, Ganguly M, et al. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res 2013;73:1892-9.
115. Alkins RD, Brodersen PM, Sodhi RN, et al. Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound. Neuro Oncol 2013;15:1225-35.
116. Park EJ, Zhang YZ, Vykhodtseva N, et al. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 2012;163:277-84.
117. Treat LH, McDannold N, Zhang Y, et al. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 2012;38:1716-25.
118. Yang FY, Wong TT, Teng MC, et al. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J Control Release 2012;160:652-8.
119. Ting CY, Fan CH, Liu HL, et al. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 2012;33:704-12.
120. Yang FY, Chen YW, Chou FI, et al. Boron neutron capture therapy for glioblastoma multiforme: enhanced drug delivery and antitumor effect following blood-brain barrier disruption induced by focused ultrasound. Future Oncol 2012;8:1361-9.
121. Liu HL, Hua MY, Chen PY, et al. Blood-Brain Barrier Disruption with Focused Ultrasound Enhances Delivery of Chemotherapeutic Drugs for Glioblastoma Treatment 1. Radiology 2010;255:415-25.
122. Liu HL, Hua MY, Yang HW, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci U S A 2010;107:15205-10.
123. Chen PY, Liu HL, Hua MY, et al. Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol 2010;12:1050-60.
124. Yang FY, Teng MC, Lu M, et al. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound. Int J Nanomedicine 2012;7:965-74.
125. McDannold N, Zhang Y, Vykhodtseva N. Blood-brain barrier disruption and vascular damage induced by ultrasound bursts combined with microbubbles can be influenced by choice of anesthesia protocol. Ultrasound Med Biol 2011;37:1259-70.
126. Delalande A, Postema M, Mignet N, et al. Ultrasound and microbubble-assisted gene delivery: recent advances and ongoing challenges. Ther Deliv 2012;3:1199-215.
127. Mullin LB, Phillips LC, Dayton PA. Nanoparticle delivery enhancement with acoustically activated microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control 2013;60:65-77.
128. Lentacker I, De Cock I, Deckers R, et al. Understanding ultrasound induced sonoporation: definitions and underlying mechanisms. Adv Drug Deliv Rev 2014;72:49-64.
129. Bao S, Thrall BD, Gies RA, et al. In vivo transfection of melanoma cells by lithotripter shock waves. Cancer Res 1998;58:219-21.
130. Miller DL, Bao S, Gies RA, et al. Ultrasonic enhancement of gene transfection in murine melanoma tumors. Ultrasound Med Biol 1999;25:1425-30.
131. Manome Y, Nakamura M, Ohno T, et al. Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. Hum Gene Ther 2000;11:1521-8.
132. Anwer K, Kao G, Proctor B, et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Ther 2000;7:1833-9.
133. Song J, Tata D, Li L, et al. Combined shock-wave and immunogene therapy of mouse melanoma and renal carcinoma tumors. Ultrasound Med Biol 2002;28:957-64.
134. Hayashi S, Mizuno M, Yoshida J, et al. Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer. Cancer Gene Ther 2009;16:638-43.
135. Casey G, Cashman JP, Morrissey D, et al. Sonoporation mediated immunogene therapy of solid tumors. Ultrasound Med Biol 2010;36:430-40.
136. Miller DL, Song J. Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Ultrasound Med Biol 2003;29:887-93.
137. Sakakima Y, Hayashi S, Yagi Y, et al. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther 2005;12:884-9.
138. Hauff P, Seemann S, Reszka R, et al. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 2005;236:572-8.
139. Li YS, Davidson E, Reid CN, et al. Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett 2009;273:62-9.
140. Tsai KC, Liao ZK, Yang SJ, et al. Differences in gene expression between sonoporation in tumor and in muscle. J Gene Med 2009;11:933-40.
141. Suzuki R, Namai E, Oda Y, et al. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 2010;142:245-50.
142. Zolochevska O, Xia X, Williams BJ, et al. Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo. Hum Gene Ther 2011;22:1537-50.
143. Sirsi SR, Hernandez SL, Zielinski L, et al. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. J Control Release 2012;157:224-34.
144. Liao ZK, Tsai KC, Wang HT, et al. Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors. Cancer Gene Ther 2012;19:171-80.
145. Kono Y, Kawakami S, Higuchi Y, et al. Antitumor effect of nuclear factor-?B decoy transfer by mannose-modified bubble lipoplex into macrophages in mouse malignant ascites. Cancer Sci 2014;105:1049-55.
146. Kono Y, Kawakami S, Higuchi Y, et al. Tumour-associated macrophages targeted transfection with NF-?B decoy/mannose-modified bubble lipoplexes inhibits tumour growth in tumour-bearing mice. J Drug Target 2014;22:439-49.
147. Rychak JJ, Klibanov AL. Nucleic acid delivery with microbubbles and ultrasound. Adv Drug Deliv Rev 2014;72:82-93.
148. Weiss N, Delius M, Gambihler S, et al. Effect of shock waves and cisplatin on cisplatin-sensitive and -resistant rodent tumors in vivo. Int J Cancer 1994;58:693-9.
149. Hoshi S, Orikasa S, Suzuki K, et al. High-energy underwater shock wave treatment for internal iliac muscle metastasis of prostatic cancer: a first clinical trial. Jpn J Cancer Res 1995;86:424-8.
150. Iwanaga K, Tominaga K, Yamamoto K, et al. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 2007;14:354-63.
151. Matsuo M, Yamaguchi K, Feril LB Jr, et al. Synergistic inhibition of malignant melanoma proliferation by melphalan combined with ultrasound and microbubbles. Ultrason Sonochem 2011;18:1218-24.
152. Yamatomo N, Iwagami T, Kato I, et al. Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas. Radiat Oncol 2013;8:280.
153. Sato T, Mori S, Arai Y, et al. The combination of intralymphatic chemotherapy with ultrasound and nano-/microbubbles is efficient in the treatment of experimental tumors in mouse lymph nodes. Ultrasound Med Biol 2014;40:1237-49.
154. Kotopoulis S, Delalande A, Popa M, et al. Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft. Mol Imaging Biol 2014;16:53-62.
155. Kotopoulis S, Dimcevski G, Gilja OH, et al. Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med Phys 2013;40:072902.
156. Yudina A, Lepetit-Coiffé M, De Smet M, et al. In vivo temperature controlled ultrasound-mediated intracellular delivery of cell-impermeable compounds. J Control Release 2012;161:90-7.
157. Robertson CA, Evans DH, Abrahamse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 2009;96:1-8.
158. O'Connor AE, Gallagher WM, Byrne AT. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009;85:1053-74.
159. Triesscheijn M, Baas P, Schellens JH, et al. Photodynamic therapy in oncology. Oncologist 2006;11:1034-44.
160. Nielsen KP, Juzeniene A, Juzenas P, et al. Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem Photobiol 2005;81:1190-4.
161. Moriwaki SI, Misawa J, Yoshinari Y, et al. Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed 2001;17:241-3.
162. Ohmura T, Fukushima T, Shibaguchi H, et al. Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep-seated intracranial glioma in rat. Anticancer Res 2011;31:2527-33.
163. Nonaka M, Yamamoto M, Yoshino S, et al. Sonodynamic therapy consisting of focused ultrasound and a photosensitizer causes a selective antitumor effect in a rat intracranial glioma model. Anticancer Res 2009;29:943-50.
164. Tang W, Liu Q, Wang X, et al. Potential mechanism in sonodynamic therapy and focused ultrasound induced apoptosis in sarcoma 180 cells in vitro. Ultrasonics 2009;49:786-93.
165. Wang X, Wang P, Zhang K, et al. Initiation of autophagy and apoptosis by sonodynamic therapy in murine leukemia L1210 cells. Toxicol In Vitro 2013;27:1247-59.
166. Su X, Wang P, Wang X, et al. Apoptosis of U937 cells induced by hematoporphyrin monomethyl ether-mediated sonodynamic action. Cancer Biother Radiopharm 2013;28:207-17.
167. Umemura S, Yumita N, Nishigaki R, et al. Mechanism of cell damage by ultrasound in combination with hematoporphyrin. Jpn J Cancer Res 1990;81:962-6.
168. Shibaguchi H, Tsuru H, Kuroki M, et al. Sonodynamic cancer therapy: a non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer. Anticancer Res 2011;31:2425-9.
169. Trendowski M. The promise of sonodynamic therapy. Cancer Metastasis Rev 2014;33:143-60.
170. Chen H, Zhou X, Gao Y, et al. Recent progress in development of new sonosensitizers for sonodynamic cancer therapy. Drug Discov Today 2014;19:502-9.
171. Kim J, Chung DJ, Jung SE, et al. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma < 5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations. Br J Radiol 2012;85:e940-6.
172. Li C, Zhang W, Zhang R, et al. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma. Eur J Cancer 2010;46:2513-21.
173. Finley DS, Pouliot F, Shuch B, et al. Ultrasound-based combination therapy: potential in urologic cancer. Expert Rev Anticancer Ther 2011;11:107-13.
174. Wang S, Zderic V, Frenkel V. Extracorporeal, low-energy focused ultrasound for noninvasive and nondestructive targeted hyperthermia. Future Oncol 2010;6:1497-511.
175. Kampinga HH. Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field. Int J Hyperthermia 2006;22:191-6.
176. Diaz RJ, McVeigh PZ, O'Reilly MA, et al. Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: potential for targeting experimental brain tumors. Nanomedicine 2014;10:1075-87.